Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution.
Treatment of in-stent restenosis remains a therapeutic challenge. Twenty-seven lesions with in-stent restenosis were treated with non-polymer-based paclitaxel-eluting stents. At 6-month follow-up, in-stent late loss was 0.44 +/- 0.54 mm and the restenosis rate was 20%, indicating effective treatment for reduction of recurrent restenosis.
Hoffmann
Rainer
R
Medical Clinic I, University Aachen, Aachen, Germany. rhoffmann@ukaachen.de
Langenberg
Roswitha
R
Radke
Peter
P
Kühl
Harald
H
Ortlepp
Jan
J
Blindt
Rüdiger
R
Grube
Eberhard
E
D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D005060:Europe; D005260:Female; D006131:Growth Inhibitors / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*; D011108:Polymers; D015607:Stents; D016896:Treatment Outcome
D006131:Growth Inhibitors; D011108:Polymers; D017239:Paclitaxel